Literature DB >> 23374005

Predicting axillary sentinel node status in patients with primary breast cancer.

D Kolarik1, V Pecha, M Skovajsova, J Zahumensky, M Trnkova, L Petruzelka, M Halaska, O Sottner, M Otcenasek, H Kolarova.   

Abstract

The aim of this study is to determine the combination of characteristics in early breast cancer that could estimate the risk of occurrence of metastatic cells in axillary sentinel lymph node(s). If we were able to reliably predict the presence or absence of axillary sentinel involvement, we could spare a considerable proportion of patients from axillary surgery without compromising therapeutic outcomes of their disease. The study is based on retrospective analysis of medical records of 170 patients diagnosed with primary breast cancer. These women underwent primary surgery of the breast and axilla in which at least one sentinel lymph node was obtained. Logistic regression has been employed to construct a model predicting axillary sentinel lymph node involvement using preoperative and postoperative tumor characteristics. Postoperative model uses tumor features obtained from definitive histology samples. Its predictive capability expressed by receiver operating characteristic curve is good, area under curve (AUC) equals to 0.78. The comparison between preoperative and postoperative results showed the only significant differences in values of histopathological grading; we have considered grading not reliably stated before surgery. In preoperative model only the characteristics available and reliably stated at the time of diagnoses were used. The predictive capability of this model is only fair when using the data available at the time of diagnosis (AUC = 0.66). We conclude, that predictive models based on postoperative values enable to reliably estimate the likelihood of occurrence of axillary sentinel node(s) metastases. This can be used in clinical practice in case surgical procedure is divided into two steps, breast surgery first and axillary surgery thereafter. Even if preoperative values were not significantly different from postoperative ones (except for grading), the preoperative model predictive capability is lower compared to postoperative values. The reason for this worse prediction was identified in imperfect preoperative diagnostic.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23374005     DOI: 10.4149/neo_2013_045

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  6 in total

1.  Detecting Abnormal Axillary Lymph Nodes on Mammograms Using a Deep Convolutional Neural Network.

Authors:  Frederik Abel; Anna Landsmann; Patryk Hejduk; Carlotta Ruppert; Karol Borkowski; Alexander Ciritsis; Cristina Rossi; Andreas Boss
Journal:  Diagnostics (Basel)       Date:  2022-05-29

2.  Development and validation of a nomogram for prediction of lymph node metastasis in early-stage breast cancer.

Authors:  Huan Li; Lin Tang; Yajuan Chen; Ling Mao; Hui Xie; Shui Wang; Xiaoxiang Guan
Journal:  Gland Surg       Date:  2021-03

3.  Development of nomograms to predict axillary lymph node status in breast cancer patients.

Authors:  Kai Chen; Jieqiong Liu; Shunrong Li; Lisa Jacobs
Journal:  BMC Cancer       Date:  2017-08-23       Impact factor: 4.430

4.  Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer Using Mammography-Based Radiomics Method.

Authors:  Jingbo Yang; Tao Wang; Lifeng Yang; Yubo Wang; Hongmei Li; Xiaobo Zhou; Weiling Zhao; Junchan Ren; Xiaoyong Li; Jie Tian; Liyu Huang
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

5.  Could Ultrasound-Based Radiomics Noninvasively Predict Axillary Lymph Node Metastasis in Breast Cancer?

Authors:  Xiaoying Qiu; Yongluo Jiang; Qiyu Zhao; Chunhong Yan; Min Huang; Tian'an Jiang
Journal:  J Ultrasound Med       Date:  2020-04-24       Impact factor: 2.153

6.  Prediction of Metastasis in the Axillary Lymph Nodes of Patients With Breast Cancer: A Radiomics Method Based on Contrast-Enhanced Computed Tomography.

Authors:  Chunmei Yang; Jing Dong; Ziyi Liu; Qingxi Guo; Yue Nie; Deqing Huang; Na Qin; Jian Shu
Journal:  Front Oncol       Date:  2021-09-20       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.